Company registration number 13500298 (England and Wales)
LIFE HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
LIFE HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
LIFE HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
56,820
75,956
Tangible assets
5
17,745
19,515
74,565
95,471
Current assets
Stocks
385,471
447,314
Debtors
6
563,492
688,343
Cash at bank and in hand
331,252
333,173
1,280,215
1,468,830
Creditors: amounts falling due within one year
7
(409,395)
(473,019)
Net current assets
870,820
995,811
Total assets less current liabilities
945,385
1,091,282
Creditors: amounts falling due after more than one year
8
(499,900)
(544,467)
Provisions for liabilities
(4,361)
(4,399)
Net assets
441,124
542,416
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
441,024
542,316
Total equity
441,124
542,416
LIFE HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 8 April 2026 and are signed on its behalf by:
Mr C D Pittock
Director
Company registration number 13500298 (England and Wales)
LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Life Healthcare Limited is a private company limited by shares incorporated, registered and trading in England and Wales with company number 13500298. The registered office is 20 Upland Road, Bexleyheath, England, DA7 4NR.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Trademarks
20% straight line
LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% reducing balance
Fixtures and fittings
20% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.15

FRS102 revisions

In September 2024, The Financial Reporting Council issued a revised edition of FRS102, effective for accounting periods beginning on or after 1 January 2026. The company has not early adopted the revised standard. The directors are assessing the impact of the revised requirements, particularly in relation to revenue recognition and lease accounting. At the date of approval of these financial statements, it is not practicable to quantify the effect of the changes.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
12
14
4
Intangible fixed assets
Goodwill
Trademarks
Total
£
£
£
Cost
At 1 January 2025 and 31 December 2025
75,367
58,000
133,367
Amortisation and impairment
At 1 January 2025
22,611
34,800
57,411
Amortisation charged for the year
7,536
11,600
19,136
At 31 December 2025
30,147
46,400
76,547
Carrying amount
At 31 December 2025
45,220
11,600
56,820
At 31 December 2024
52,756
23,200
75,956
LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
5
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 January 2025
24,120
4,577
28,697
Additions
-
0
2,148
2,148
At 31 December 2025
24,120
6,725
30,845
Depreciation and impairment
At 1 January 2025
8,183
999
9,182
Depreciation charged in the year
3,187
731
3,918
At 31 December 2025
11,370
1,730
13,100
Carrying amount
At 31 December 2025
12,750
4,995
17,745
At 31 December 2024
15,937
3,578
19,515
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
413,724
555,138
Other debtors
149,768
133,205
563,492
688,343
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
4,167
10,000
Trade creditors
261,975
273,411
Taxation and social security
109,371
156,696
Other creditors
33,882
32,912
409,395
473,019
LIFE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
-
0
4,167
Other creditors
499,900
540,300
499,900
544,467
9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
20,265
35,266
10
Related party transactions

Included in other debtors are loans from the directors and shareholders of the company's parent undertaking totaling £62,725 (2024 - £81,656). No interest is charged and there is no fixed term for repayment.

Included in other creditors falling due within one year are loans from the directors and shareholders of the company's parent undertaking totaling £nil (2024 - £7,375). Interest was charged by each party at a commercial rate. The loans are repayable on demand.

11
Parent company

The parent company of Life Healthcare Limited is Life Healthcare Holdings Limited, registered in the United Kingdom with company number 13812793, and its registered office is: 20 Upland Road, Bexleyheath, England, DA7 4NR.

2025-12-31 2025-01-01 false false false 08 April 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr C D Pittock Mr H Pittock Mr S Pittock Mr C Kingston 13500298 2025-01-01 2025-12-31 13500298 2025-12-31 13500298 2024-12-31 13500298 core:Goodwill 2025-12-31 13500298 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-12-31 13500298 core:Goodwill 2024-12-31 13500298 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-12-31 13500298 core:PlantMachinery 2025-12-31 13500298 core:FurnitureFittings 2025-12-31 13500298 core:PlantMachinery 2024-12-31 13500298 core:FurnitureFittings 2024-12-31 13500298 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 13500298 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 13500298 core:CurrentFinancialInstruments 2025-12-31 13500298 core:CurrentFinancialInstruments 2024-12-31 13500298 core:Non-currentFinancialInstruments 2025-12-31 13500298 core:Non-currentFinancialInstruments 2024-12-31 13500298 core:ShareCapital 2025-12-31 13500298 core:ShareCapital 2024-12-31 13500298 core:RetainedEarningsAccumulatedLosses 2025-12-31 13500298 core:RetainedEarningsAccumulatedLosses 2024-12-31 13500298 bus:Director1 2025-01-01 2025-12-31 13500298 core:Goodwill 2025-01-01 2025-12-31 13500298 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 13500298 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 13500298 core:PlantMachinery 2025-01-01 2025-12-31 13500298 core:FurnitureFittings 2025-01-01 2025-12-31 13500298 2024-01-01 2024-12-31 13500298 core:Goodwill 2024-12-31 13500298 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-12-31 13500298 2024-12-31 13500298 core:PlantMachinery 2024-12-31 13500298 core:FurnitureFittings 2024-12-31 13500298 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13500298 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13500298 bus:FRS102 2025-01-01 2025-12-31 13500298 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 13500298 bus:Director2 2025-01-01 2025-12-31 13500298 bus:Director3 2025-01-01 2025-12-31 13500298 bus:Director4 2025-01-01 2025-12-31 13500298 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP